Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

Share Price is delayed by 15 minutes
Get Live Data
7,115.00    -15.00 (-0.21%)
Bid:
7,110.00
Ask:
7,120.00
Spread: 10.00 (0.141%)
Market Cap: £9.54b
DPLM Live PriceLast checked at - London Stock Exchange

Intraday Diploma Share Chart

Acquisition

10 Sep 2010 07:00

RNS Number : 4595S
Diploma PLC
10 September 2010
 



 

DIPLOMA PLC

12 CHARTERHOUSE SQUARE, LONDON EC1M 6AX

TELEPHONE: +44 (0)20 7549 5700

FACSIMILE: +44 (0)20 7549 5715

 

FOR IMMEDIATE RELEASE

 

10 September 2010

 

 

DIPLOMA PLC

 

DIPLOMA ACQUIRES AN OEM SEALS BUSINESS IN THE UNITED STATES AND A HEALTHCARE BUSINESS IN AUSTRALIA

 

 

Diploma PLC, the international group of businesses supplying specialised technical products and services, is pleased to announce the acquisition of 100% of All Seals Inc ("All Seals") for a maximum consideration of £7.8m (US$11.9m), before expenses. On 30 July 2010, Diploma PLC also completed the acquisition of 80% of Big Green Surgical Company Pty Limited ("BGS") for a maximum consideration of £1.4m (A$2.4m), before expenses.

 

All Seals Inc

 

All Seals is a well established supplier of O rings and custom moulded seals to Industrial OEM customers across a range of specialist applications in aerospace, medical, agriculture and general manufacturing industries. All Seals employs 22 staff and operates from a leased facility in Santa Ana, California in the United States.

 

All Seals will join the Hercules Fluid Power Group ("HFPG"), Diploma's North American Seals Group, alongside HFPG's other OEM seal business, RT Dygert. All Seals and RT Dygert will be complementary businesses within HFPG as All Seals sells ca. 75% of its product in California and the South Western states of the US, while RT Dygert is concentrated in the Mid-West.

 

At the time of acquisition, All Seals was owned by Mr J Barnett who will remain as an Executive until 31 December 2010, and thereafter be available as a consultant to the business.

 

Unaudited revenues of All Seals in the year ended 31 December 2009, when industrial markets were particularly weak, were US$7.8m (£5.1m). In the first eight months of 2010, revenues have rebounded strongly and are ca. 30% ahead of the prior comparable period.

 

The initial cash consideration for All Seals will be US$10.5m (£6.9m), which will be met from the Group's existing cash resources. This may be subject to minor adjustment based on the net assets at completion. Further deferred consideration up to an aggregate maximum of US$1.4m (£0.9m) may be payable in 2011, depending primarily on the operating profit out-turn of the business in the year ending 31 December 2010.

 

Big Green Surgical Company Pty Limited

 

BGS is a specialised distributor of electrosurgery consumables and equipment supplied to both public and private hospitals in Australia and New Zealand. The business is a smaller, more narrowly focused version of the Group's existing AMT Electrosurgery business in Canada and shares a number of common suppliers. BGS employs 6 staff and operates from a small leased facility in Newcastle, close to Sydney in New South Wales, Australia.

 

At the time of acquisition, BGS was jointly owned by Mr & Mrs A Bennett and Mr Bennett will remain in place as Managing Director following the acquisition for a minimum period of three years. BGS will report directly into the management team of Diploma's Canadian Healthcare businesses.

 

In the year ended 30 June 2010, BGS reported unaudited revenues of A$3.4m (£2.0m). The initial consideration paid for 80% of the share capital was A$2.4m (£1.4m). The outstanding 20% of shares will be retained by the Managing Director for three years and be subject to put/call options, based on an agreed multiple of operating profit.

 

The Board expects both acquisitions to be immediately earnings enhancing for the Group.

 

Bruce Thompson, Chief Executive of Diploma PLC said:

 

"The acquisition of All Seals is an important addition to our developing OEM Seals business in North America. The BGS acquisition, although relatively small, is strategically important in opening up new geographic opportunities for our established Healthcare business."

 

 

 

 

For further enquiries please contact:

Bruce Thompson, Chief Executive Officer

020 7549 5700

Nigel Lingwood, Group Finance Director

020 7549 5705

Simon Bloomfield, Bankside Consultants

020 7367 8861

 

 

 

 

NOTE TO EDITORS:

 

Diploma PLC is an international group of businesses supplying specialised technical products and services to the Life Sciences, Seals and Controls industries.

 

Diploma achieves stable growth and attractive margins from its focus on supplying specialised technical products to markets which value high levels of customer service, technical support and value adding activities. A high proportion of revenues are generated from essential products and services funded by operating, rather than capital budgets.

 

The Group employs ca. 825 employees and its principal operating businesses are located in the UK, Germany, US and Canada.

 

Over the last five years, the Group has grown adjusted earnings per share at an average of ca. 16% p.a. through a combination of organic growth and acquisitions. The current market capitalisation is ca. £290m.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQKKCDBABKDKCK
Date   Source Headline
16th Jan 202010:40 amRNSResult of AGM
15th Jan 20207:00 amRNSTrading Statement
24th Dec 20197:00 amRNSDirector / PDMR Grant of LTIP Award
23rd Dec 20197:00 amRNSDirectorate Change
17th Dec 20195:09 pmRNSHolding(s) in Company
16th Dec 201912:00 pmRNSHolding(s) in Company
6th Dec 20193:27 pmRNSAnnual Financial Report & Notice of AGM
21st Nov 20194:00 pmRNSDirector/PDMR Shareholding
18th Nov 20197:00 amRNSFinal Results
8th Oct 20197:00 amRNSDirectorate Change
25th Sep 20197:00 amRNSAcquisition
10th Sep 20194:49 pmRNSHolding(s) in Company
28th Aug 20197:00 amRNSTrading Statement
8th Aug 20193:00 pmRNSHolding(s) in Company
17th Jul 20191:01 pmRNSHolding(s) in Company
11th Jul 20197:00 amRNSAcquisition
13th Jun 20192:00 pmRNSDirector Declaration
13th May 20197:00 amRNSHalf-year Report
1st Apr 20197:00 amRNSAppointment of Joint Corporate Broker
27th Mar 20197:00 amRNSHalf Year Trading Update
26th Feb 20197:00 amRNSDirector/PDMR Shareholding
25th Feb 20194:00 pmRNSDirector/PDMR Shareholding
25th Feb 20197:00 amRNSDirectorate Appointments
29th Jan 20193:30 pmRNSDirector/PDMR Shareholding
16th Jan 20194:19 pmRNSResult of AGM
16th Jan 20197:01 amRNSDirectorate Change
16th Jan 20197:00 amRNSTrading Statement
7th Dec 20184:09 pmRNSDirector/PDMR Shareholding
7th Dec 20183:00 pmRNSAnnual Financial Report & Notice of AGM
27th Nov 20184:26 pmRNSDirector/PDMR Shareholding
19th Nov 20187:00 amRNSFinal Results
12th Oct 20187:00 amRNSAcquisition
3rd Sep 20184:45 pmRNSBoard Committee Change
29th Aug 20187:01 amRNSDirectorate Change
29th Aug 20187:00 amRNSTrading Statement
22nd Aug 20187:00 amRNSAcquisition
10th Jul 20181:46 pmRNSHolding(s) in Company
12th Jun 20182:59 pmRNSHolding(s) in Company
16th May 20182:41 pmRNSDirector Declaration
15th May 20184:20 pmRNSDirector/PDMR Shareholding
15th May 20184:09 pmRNSDirector/PDMR Shareholding
14th May 20187:00 amRNSHalf-year Report
9th May 20187:00 amRNSDirectorate Change
23rd Apr 20187:00 amRNSDirectorate Change
28th Mar 20187:00 amRNSTrading Update
21st Mar 20189:30 amRNSHolding(s) in Company
20th Mar 20184:00 pmRNSHolding(s) in Company
6th Feb 20189:49 amRNSDirector/PDMR Shareholding
30th Jan 20187:00 amRNSDirectorate Change
23rd Jan 20184:00 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.